Aspaveli Unia Europejska - fiński - EMA (European Medicines Agency)

aspaveli

swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuria, paroxysmal - immunosuppressantit - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.

Kandrozid 4 mg tabletti Finlandia - fiński - Fimea (Suomen lääkevirasto)

kandrozid 4 mg tabletti

viatris limited - candesartan cilexetil - tabletti - 4 mg - kandesartaani

Kandrozid 8 mg tabletti Finlandia - fiński - Fimea (Suomen lääkevirasto)

kandrozid 8 mg tabletti

viatris limited - candesartan cilexetil - tabletti - 8 mg - kandesartaani

Kandrozid 16 mg tabletti Finlandia - fiński - Fimea (Suomen lääkevirasto)

kandrozid 16 mg tabletti

viatris limited - candesartan cilexetil - tabletti - 16 mg - kandesartaani

Kandrozid 32 mg tabletti Finlandia - fiński - Fimea (Suomen lääkevirasto)

kandrozid 32 mg tabletti

viatris limited - candesartan cilexetil - tabletti - 32 mg - kandesartaani